Form 4: WW International Director Awarded Equity Grant

Sentiment:

Insider Transaction Report


WW International Director Julie Bornstein was granted 1,219 shares of common stock as compensation for her board service, as disclosed in a recent SEC Form 4 filing.

Summary

  • WW International, Inc. Director Julie Bornstein was granted 1,219 shares of common stock on December 19, 2025.
  • The award was compensation for her service as a member of the Issuer's Board of Directors during the third quarter of fiscal 2025.
  • The shares were granted at a price of $0.00 per share, indicating a non-cash award.
  • Following this transaction, Julie Bornstein beneficially owns a total of 1,752 shares of WW International, Inc. common stock.
  • The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
  • The shares are subject to transfer restrictions.

Sentiment

Score: 5

Explanation: The filing is neutral, reporting a routine equity grant as part of director compensation. It does not contain information that would significantly alter the company's financial outlook or operational performance.

Positives

  • The equity grant serves as compensation for Director Julie Bornstein's service on the Board, aligning her interests with shareholders.
  • The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged and transparent compensation structure.

Risks

  • The Limited Power of Attorney explicitly states that neither the Company nor the attorneys-in-fact assume any liability for the undersigned's responsibility to comply with SEC reporting requirements (Exchange Act, Securities Act, Rule 144), nor for any failure to comply or for profit disgorgement under Section 16(b) of the Exchange Act. This places the ultimate compliance burden solely on the reporting person, Julie Bornstein.

Future Outlook

The filing reports a future equity grant to Director Julie Bornstein on December 19, 2025, as part of her compensation for Q3 fiscal 2025 board service. The shares are subject to transfer restrictions.

Industry Context

This Form 4 filing represents a routine insider transaction related to director compensation, which is a standard practice across publicly traded companies to align management and board interests with shareholders. It does not provide broader industry insights.

Comparison to Industry Standards

  • Equity grants as part of director compensation are a common practice in publicly traded companies, aligning director incentives with company performance and shareholder value, consistent with general industry standards.
  • The use of a Rule 10b5-1(c) plan for such transactions is also a standard corporate governance practice, promoting transparency and mitigating concerns about insider trading.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Power of Attorney EstablishmentJulie Bornstein executed a Limited Power of Attorney, appointing Jacqueline Cooke, Debra Cotter, Roxanne Tingir, and Ashley Chaffin as attorneys-in-fact to prepare and file SEC Forms 3, 4, 5, and 144 on her behalf.October 24, 2025Streamlines the process for the director to comply with Section 16 reporting obligations, ensuring timely and accurate filings. However, it explicitly states the director retains ultimate responsibility for compliance.

Related Party Transactions

  • The equity grant to Director Julie Bornstein constitutes a related party transaction, representing compensation for her board service.

Stakeholder Impact

  • Shareholders: The grant is a form of non-cash compensation for a director, aligning her interests with shareholder value. It is a routine expense for the company.
  • Director (Julie Bornstein): Receives additional equity in the company, increasing her direct ownership and potential for future gains based on company performance.

Next Steps

  • The shares granted are subject to transfer restrictions, which will need to be observed by the reporting person.

Key Dates

DateDescription
October 24, 2025Execution date of the Limited Power of Attorney by Julie Bornstein.
December 19, 2025Date of the equity grant transaction for 1,219 shares of common stock.
December 22, 2025Date the Form 4 was signed by the attorney-in-fact and filed with the SEC.

Keywords

WW International, WW, Julie Bornstein, Director, Equity Grant, Stock Award, Form 4, SEC Filing, Insider Transaction, Compensation, Corporate Governance, Rule 10b5-1

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.